HeatSYNC for Uterine Fibroids
Uterine Fibroids
Pre-clinicalActive
Key Facts
About Theromics
Theromics is pioneering a protein-based nanopolymer platform that acts as a thermal accelerant for soft tissue ablation and targeted drug delivery. Its core technology addresses key limitations in current ablation techniques, such as heat-sink effects and irregular ablation zones, aiming to reduce the 30% recurrence rate. The platform also enables Thermally Activated Combination Therapy (TACT), which localizes therapeutics to minimize systemic side effects. The company is initially targeting applications in oncology and women's health, specifically uterine fibroids.
View full company profileTherapeutic Areas
Other Uterine Fibroids Drugs
| Drug | Company | Phase |
|---|---|---|
| GYIDE | Nesa Medtech | Preclinical |
| Exablate Platform | Insightec | CE Marked |
| Menstrual Blood Biomarker Discovery | Qvin | Research |
| Sonalleve® | Profound Medical | Commercial |